-
EDITORIAL
Advancements in drug delivery systems, challenges and future opportunities
J. P. Pearson
-
COVER STORY
BACHEM – KEY TO THE NEXT HEALTHCARE REVOLUTION: TECHNOLOGICAL LEADERSHIP – A leading CDMO’s perspective
-
AI
AI and ESG Role in Optimizing mRNA and Protein-Based Vaccines Supply Chains From Raw Material Sourcing to Last-Mile Delivery
A. Pesqueira
-
ADVERTORIAL
WuXi TIDES – The Role of Benchmarking Critical Impurity Control in Therapeutic Oligonucleotide Phosphoramidites
-
GREEN CHEMISTRY
Smarter Chemistry: Green, Circular and Safe-by-Design
J. C. Slootweg
-
GREEN CHEMISTRY
Design to Refine for Homogeneous Catalysts
D. Arnold, R. Higgins, D. Holdsworth
-
OLIGONUCLEOTIDES & PEPTIDES
Antibody-Oligonucleotide Conjugation – Chemistry, Biology and Therapeutics
X. Wan, M. Bhalla, S. Bose
-
OLIGONUCLEOTIDES & PEPTIDES
Strategies for Enhancing Sustainability in Peptide Synthesis: Minimal-Protection and Minimal-Rinsing SPPS
Y. Yang
-
OLIGONUCLEOTIDES & PEPTIDES
Liquid-Phase Peptide Synthesis (LPPS): A Sustainable Future for Peptide Therapeutics
M. Bio
-
PACKAGING
System thinking: The untold story of sustainability in primary pharma packaging
A. Van Batavia
-
DRUG FORMS
The five senses to the rescue of observance, utopia or next future?
P. Gauthier
-
A WORD WITH
Olaf STANGE, Chair of the Together for Sustainability (TfS) Initiative workstream on Scope 3 greenhouse gas (GHG) emissions
-
GENERICS
Launching Generic Pharmaceuticals with a Patient-Centric Approach
J. Kim
-
GENERICS
Portfolio Management for Generics: 40 Years of Evolution and Rising Complexity
A. Gavalda Escude
-
CDMO
Enabling a sustainable and mutually beneficial CDMO partnership
A. Boland
-
COLUMN: API OF THE MONTH
Seladelpar
R. Souza
-
COLUMN: THE SPECIALTY CHEMICALS MARKET
A New Chapter for Non-U.S. Specialty Chemical Companies in the Trump Administration
J. Abril
